In the ZEUS study, we will investigate if the study medicine called ‘Ziltivekimab’ can reduce the risk of stroke, heart attack and death, from cardiovascular causes in people with inflammation in their blood vessels.
Request to participate today.

The MATISSE maternal vaccine study wants to find out if giving expecting mothers an investigational vaccine for respiratory syncytial virus (RSV) is safe and could help protect their babies from RSV after they are born.

Learn more about a study vaccine, including whether it may help boost the level of RSV-fighting antibodies in pregnant women and whether those antibodies pass to their babies and may help protect babies against RSV disease.